What to Expect in October's HIV/AIDS Section of Contagion®
OCT 10, 2019 | CONTAGION® EDITORIAL STAFF
Segment Description: Jason Schafer, PharmD, MPH, BCPS AQ-ID, associate professor in the Department of Pharmacy Practice at Jefferson College of Pharmacy at Thomas Jefferson University, and content editor of the HIV/AIDS section of Contagion®, previews the October issue featuring an article on rapid initiation of antiretroviral therapy.
Interview transcript: (modified slightly for readability)
Dr. Schafer: In the October issue of Contagion®, we do have an article by Dr. Bill Short on rapid initiation of antiretroviral therapy (ART). This is a considerably important topic and [there are] a lot of emerging data available about this topic and the benefits that people can have when receiving ART perhaps more quickly than we used to administer ART in the past. And so, Dr. Short reviews all of the relevant data, goes through the pros and the cons of being able to do this practice, and, on the end, provides his recommendations in terms of what clinics really need to do to be able to start ART, or antiretroviral therapy, in a rapid fashion for patients.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512